NCT03998878

Brief Summary

This project will test 3 methods of dietary changes in a weight loss clinic. Participants will be randomized to one of 3 arms: low-carbohydrate diet, intermittent energy restriction, or Hunger Training. A maximum of 30 participants will be assigned to each arm. The goal of the proposed study is to determine the feasibility, early efficacy, and patient satisfaction of each weight loss modality in a population of patients seeking care at a weight loss clinic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 26, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

August 8, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2021

Completed
Last Updated

December 17, 2021

Status Verified

December 1, 2021

Enrollment Period

2.4 years

First QC Date

June 24, 2019

Last Update Submit

December 16, 2021

Conditions

Keywords

Weight LossDiet ModificationBody WeightBody Weight ChangesKetogenic dietDiet, Carbohydrate-RestrictedFastingIntermittent FastingHunger training

Outcome Measures

Primary Outcomes (19)

  • Rate of Recruitment

    Feasibility of recruiting participants into a randomized dietary intervention in a clinic setting as measured by the total number of individuals who are screened as eligible and enrolled into the study

    1 year

  • Rate of Retention

    Feasibility of retaining participants in a randomized dietary intervention in a clinic setting as measured by the number of participants completing all study visits

    1 year

  • Adherence to the Intervention

    Feasibility of maintaining participant adherence in a randomized dietary intervention in a clinic setting will be measured by attendance at scheduled clinic visits

    1 year

  • Change in Weight

    Participant weight will be measured

    baseline to 3 months

  • Change in BMI

    Participant BMI will be measured

    baseline to 3 months

  • Change in HbA1c

    Participant HbA1c will be measured

    baseline to 3 months

  • Change in Fasting Glucose

    Participant fasting glucose will be measured

    baseline to 3 months

  • Change in Fasting Insulin

    Participant fasting insulin will be measured

    baseline to 3 months

  • Change in Total Cholesterol

    Participant total cholesterol will be measured

    baseline to 3 months

  • Change in Triglycerides

    Participant triglycerides will be measured

    baseline to 3 months

  • Change in High Density Lipoprotein (HDL)

    Participant HDL will be measured

    baseline to 3 months

  • Change in Low Density Lipoprotein (LDL)

    Participant LDL will be measured

    baseline to 3 months

  • Change in C-Reactive Protein (CRP)

    Participant CRP will be measured

    baseline to 3 months

  • Change in Insulin-like Growth Factor 1 (IGF-1)

    Participant IGF-1 will be measured

    baseline to 3 months

  • Change in Insulin-like Growth Factor 2 (IGF-2)

    Participant IGF-2 will be measured

    baseline to 3 months

  • Change in Insulin-like Growth Factor Binding Protein 3 (IGFBP-3)

    Participant IGFBP-3 will be measured

    baseline to 3 months

  • Change in Leptin

    Participant leptin will be measured

    baseline to 3 months

  • Change in Adiponectin

    Participant adiponectin will be measured

    baseline to 3 months

  • Participant Satisfaction

    Participants will complete a questionnaire at the end of the study to assess the acceptability of and satisfaction with the weight loss diet intervention they received. We will assess overall satisfaction, enjoyment, likeliness to recommend, and ease of following the diet. Aggregated scores will be compared across weight loss modality.

    3 months

Study Arms (3)

Low-Carbohydrate Diet

EXPERIMENTAL

Participants will be instructed to consume less than 30 grams of carbohydrates per day.

Behavioral: Low-Carbohydrate Diet

Intermittent Energy Restriction

EXPERIMENTAL

Participants choose 2 non-consecutive days per week in which they will consume 500-650 calories.

Behavioral: Intermittent Energy Restriction

Hunger Training

EXPERIMENTAL

Participants monitor their hunger symptoms and blood glucose, and eat only when blood glucose is below a certain threshold level.

Behavioral: Hunger Training

Interventions

Participants will be instructed to follow a low-carbohydrate diet.

Low-Carbohydrate Diet

Participants will be instructed to follow intermittent energy restriction.

Intermittent Energy Restriction
Hunger TrainingBEHAVIORAL

Participants will be instructed to follow Hunger Training.

Hunger Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Overweight/obese as indicated by BMI \>27
  • Age ≥ 18
  • HbA1C \<8.0
  • Fluent in English

You may not qualify if:

  • Cognitive state that precludes informed consent or adherence to study protocols
  • Pregnant, breast-feeding, or planning to become pregnant within 6 months
  • A1C ≥ 8.0
  • Taking an anti-obesity medication
  • Insulin-dependence
  • prior metabolic surgery
  • current laparoscopic adjustable gastric band ("lap band") use
  • Experience of substantial weight changes (±5 kg or ±10 lbs) in the past 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona

Tucson, Arizona, 85714, United States

Location

MeSH Terms

Conditions

ObesityWeight LossBody WeightBody Weight ChangesFastingIntermittent Fasting

Interventions

Diet, Carbohydrate-Restricted

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Amit Algotar, MD, PhD, MPH

    University of Arizona, Banner University Medical Center

    PRINCIPAL INVESTIGATOR
  • Susan M Schembre, PhD, RD

    University of Arizona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2019

First Posted

June 26, 2019

Study Start

August 8, 2019

Primary Completion

December 16, 2021

Study Completion

December 16, 2021

Last Updated

December 17, 2021

Record last verified: 2021-12

Locations